deferiprone has been researched along with amyloid beta-peptides in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dasari, B; Dickson, A; Ghribi, O; Kirsch, WM; Marwarha, G; Prasanthi, JR; Schrag, M | 1 |
1 other study(ies) available for deferiprone and amyloid beta-peptides
Article | Year |
---|---|
Deferiprone reduces amyloid-β and tau phosphorylation levels but not reactive oxygen species generation in hippocampus of rabbits fed a cholesterol-enriched diet.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Analysis of Variance; Animals; Aspartic Acid Endopeptidases; Cholesterol; Deferiprone; Dietary Supplements; Disease Models, Animal; Dose-Response Relationship, Drug; Hippocampus; Iron; Iron Chelating Agents; Male; Peptide Fragments; Phosphorylation; Pyridones; Rabbits; Reactive Oxygen Species | 2012 |